Patents by Inventor George Paul Tuszynski

George Paul Tuszynski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIMVASTATIN AND CHEMOTHERAPEUTIC CONJUGATES WITH A HEPTAMETHINE CARBOCYANINE DYE RESENSITIZE HUMAN TUMORS TO HORMONAL ANTAGONISTS AND CHEMOTHERAPY
    Publication number: 20190269801
    Abstract: This application relates to dye-therapeutic moiety conjugates for imaging, targeting, and treating cancerous cells and/or tumors.
    Type: Application
    Filed: October 21, 2017
    Publication date: September 5, 2019
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Leland W. K. Chung, Stefan Mrdenovic, Yi Zhang, Gina Chi-Yi Chu, Ruoxiang Wang, Frank N. Chang, George Paul Tuszynski
  • Synthetic analogs of thrombospondin and therapeutic use thereof
    Patent number: 6239110
    Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 29, 2001
    Assignees: W.R. Grace & Co. -Conn., Medical College of PA
    Inventors: Jacob Eyal, Bruce King Hamilton, George Paul Tuszynski
  • Peptide fragments and analogs of thrombospondin
    Patent number: 5840692
    Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 24, 1998
    Assignees: Allegheny University of the Health Sciences, W. R. Grace, Co. - Conn.
    Inventors: Alan Howard Deutch, George Paul Tuszynski
  • Peptides having thrombospondin-like activity and their therapeutic use
    Patent number: 5654277
    Abstract: Methods of use of compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided for promoting or inhibiting thrombospondin-like activity.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: August 5, 1997
    Assignees: W. R. Grace & Co.-Conn., The Medical College of Pennsylvania
    Inventors: Jacob Eyal, Bruce King Hamilton, George Paul Tuszynski
  • Synthetic analogs of thrombospondin and therapeutic use thereof
    Patent number: 5648461
    Abstract: Compounds and compositions comprising fragments and synthetic analogs of human thrombospondin are provided together with methods for their use as thrombospondin-like agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 15, 1997
    Assignees: W.R. Grace & Co.-Conn, The Medical College of Pennsylvania
    Inventors: Jacob Eval, Bruce King Hamilton, George Paul Tuszynski